Nathan Weinstein
Stock Analyst at Aegis Capital
(0.27)
# 4,163
Out of 4,876 analysts
61
Total ratings
13.33%
Success rate
-26.12%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.28 | +6,150.00% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $0.69 | +2,089.46% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.87 | +591.24% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.71 | +4,826.80% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.21 | +171.49% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.19 | +1,269.86% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $5.66 | +76.68% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $19.43 | +152.19% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $5,250 → $150 | $1.27 | +11,711.02% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $4.10 | +52,582.93% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.19 | +2,413.40% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.84 | +1,097.60% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $48.03 | +233.13% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.32 | +104.98% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $2.25 | +1,100.00% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.74 | +4,652.21% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.00 | +500.00% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $8.93 | +739.87% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $3.07 | +2,766.45% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $2.05 | +8,680.49% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $3.57 | +3,681.51% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.47 | +116.38% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $15.90 | +1,283.65% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.38 | +151.48% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.28
Upside: +6,150.00%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $0.69
Upside: +2,089.46%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.87
Upside: +591.24%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.71
Upside: +4,826.80%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.21
Upside: +171.49%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.19
Upside: +1,269.86%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $5.66
Upside: +76.68%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $19.43
Upside: +152.19%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $5,250 → $150
Current: $1.27
Upside: +11,711.02%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $4.10
Upside: +52,582.93%
Dec 7, 2021
Initiates: Buy
Price Target: $30
Current: $1.19
Upside: +2,413.40%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.84
Upside: +1,097.60%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $48.03
Upside: +233.13%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $27.32
Upside: +104.98%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $2.25
Upside: +1,100.00%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.74
Upside: +4,652.21%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $2.00
Upside: +500.00%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $8.93
Upside: +739.87%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $3.07
Upside: +2,766.45%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $2.05
Upside: +8,680.49%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $3.57
Upside: +3,681.51%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.47
Upside: +116.38%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $15.90
Upside: +1,283.65%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.38
Upside: +151.48%